PACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1b
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Cyclin D1 overexpression is a common feature of many human malignancies. Genomic deletion analysis has demonstrated a key role for cyclin D1 in cellular proliferation, angiogenesis, and cellular migration. To investigate the mechanisms contributing to cyclin D1 functions, we purified cyclin D1a-associated complexes by affinity chromatography and identified the PACSIN 2 (protein kinase C and casein kinase substrate in neurons 2) protein by mass spectrometry. The PACSIN 2, but not the related PACSIN 1 and 3, directly bound wild-type cyclin D1 (cyclin D1a) at the carboxyl terminus, and failed to bind cyclin D1b, the alternative splicing variant of cyclin D1. PACSIN 2 knockdown induced cellular migration and reduced cell spreading in LNCaP cells expressing cyclin D1a. In cyclin D1(-/-) mouse embryonic fibroblasts (MEFs), cyclin D1a, but not cyclin D1b, reduced the cell spreading to a polarized morphology. siPACSIN 2 had no effect on cellular migration of cyclin D1(-/-) MEFs. Cyclin D1a restored the migratory ability of cyclin D1(-/-) MEFs, which was further enhanced by knocking down PACSIN 2 with siRNA. The cyclin D1-associated protein, PACSIN 2, regulates cell spreading and migration, which are dependent on cyclin D1 expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402 · cited 1×
“Both p21 and p27 facilitate assembly of the cyclin D/CDK complexes.(8) Additional components that contribute to the molecular weight of holoenzymes have been identified in complexes ranging from 150 to 200 kDa(4,9,10) including Hsc70.”
BackgroundSpecific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934 · cited 2×
“Gastrointestinal tumors induced by mutation of the Apc gene are reduced in number by cyclin D1 deficiency.12 Consistent with findings that the cyclin D1 antisense abrogates mammary epithelial cell growth induced by ErbB2,13 cyclin D1-deficient mice are resistant to mammary gland tumorigenesis induced by Ras or ErbB2.”
Cheng, M., Sexl, V., Sherr, C. J., & Roussel, M. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1091 · Cited by 496 · cited 1×
“The sequential association requires assembly factors to bring cyclin D1 and CDK4 together.(6,7) Both p21 and p27 facilitate assembly of the cyclin D/CDK complexes.”
BackgroundMammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4
Stepanova, L., Leng, X., Parker, S. B., & Harper, J. W. (1996) · Genes & Development · doi:10.1101/gad.10.12.1491 · Cited by 483 · cited 2×
“Phosphorylation of NRF-1 represses its transactivation function thereby inhibiting mitochondrial metabolism.3 The heterodimeric partner of cyclin D1, CDK4/6, is associated in high molecular weight cytoplasmic complexes containing Hsp90 and Cdc37.”
BackgroundTranscriptional role of cyclin D1 in development revealed by a genetic-proteomic screen
Bienvenu, F., Jirawatnotai, S., Elias, J. E., Meyer, C. A., Mizeracka, K., Marson, A., Frampton, G. M., Cole, M. F., Odom, D. T., Odajima, J., et al. (2010) · Nature · doi:10.1038/nature08684 · Cited by 276
McConnell, B. B., Gregory, F. J., Stott, F. J., Hara, E., & Peters, G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1981 · Cited by 238
Wang, Q., Navarro, M. V. A. S., Peng, G., Molinelli, E., Lin Goh, S., Judson, B. L., Rajashankar, K. R., & Sondermann, H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902974106 · Cited by 200
Parry, D., Mahony, D., Wills, K., & Lees, E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1775 · Cited by 174
Hsc70 regulates accumulation of cyclin D1 and cyclin D1-dependent protein kinase
Diehl, J. A., Yang, W., Rimerman, R. A., Xiao, H., & Emili, A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.5.1764-1774.2003 · Cited by 97
Cited by
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Zhang, H., Liu, T., Zhang, Z., Payne, S. H., Zhang, B., McDermott, J. E., Zhou, J.-Y., Petyuk, V. A., Chen, L., Ray, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.069 · Cited by 1,029
Self-citationMontalto, F. I., & De Amicis, F. (2020) · Cells · doi:10.3390/cells9122648 · Cited by 496
Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts
Rashkin, S. R., Graff, R. E., Kachuri, L., Thai, K. K., Alexeeff, S. E., Blatchins, M. A., Cavazos, T. B., Corley, D. A., Emami, N. C., Hoffman, J. D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18246-6 · Cited by 289
The double dealing of cyclin D1
Tchakarska, G., & Sola, B. (2020) · Cell Cycle · doi:10.1080/15384101.2019.1706903 · Cited by 278
“Prostate** Fibroblast Not Reported PACSIN 2 YES Migration [122]”
BackgroundPestell, R. G. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.03.001 · Cited by 197
Self-citation
Metadata
- Authors
- Meng, H., Tian, L., Zhou, J., Li, Z., Jiao, X., Li, W. W., Plomann, M., Xu, Z., Lisanti, M. P., Wang, C., & Pestell, R. G.
- Venue
- Cell Cycle
- Publisher
- Informa UK Limited
- Published
- 2011-01
- Volume
- 10
- Issue
- 1
- Pages
- 73-81
- ISSN
- 1538-4101 (ISSN-L)
- 1551-4005
- OpenAlex
- W2048462000
- Cited by
- 42
- References
- 9
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.